Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Sep;394(9):1975-1981.
doi: 10.1007/s00210-021-02105-2. Epub 2021 Jul 8.

Amelioration of autoimmunity and inflammation by zinc oxide nanoparticles in experimental rheumatoid arthritis

Affiliations
Comparative Study

Amelioration of autoimmunity and inflammation by zinc oxide nanoparticles in experimental rheumatoid arthritis

Sameh S Gad et al. Naunyn Schmiedebergs Arch Pharmacol. 2021 Sep.

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects the lining of the synovial joints and approximately affects 0.5 - 1% of the total population imposing a socioeconomic burden. The current study aimed at investigating the novel possible beneficial effects of using zinc oxide nanoparticles (ZnO NPs) on such devastating disease. The complete Freund's adjuvant (CFA) model was used to mimic RA in rats where ZnO NPs were given orally (2 mg/kg/day) daily for 14 days; and diclofenac Na, the standard drug, was given intraperitoneally (1 mg/kg/day) the day after CFA, daily for 14 days. Our results displayed that ZnO NPs attenuated adjuvant-induced increased production of inflammatory mediators interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), interleukin-10 (IL-10), and total leukocyte count. Besides, they ameliorated autoimmunity through suppression of anti-citrullinated protein auto antibodies (anti-CCP) levels in rats. In conclusion our results highlight the benefits which could be obtained of nanoparticles either alone or in combination with the known anti-arthritic and/or anti-inflammatory agents, giving rise to new protocols to maximize the control of RA.

Keywords: Anti-CCP levels; Chronic disease; Rheumatoid arthritis; Rheumatoid factor; Zinc oxide nanoparticles.

PubMed Disclaimer

References

    1. A Ali A, S El-Zaitony A, Al-Haleem ENA (2016) Evaluation of therapeutic efficacy of vinpocetine in adjuvant induced arthritis model in rats. J Pain Manag Med 02: https://doi.org/10.35248/2684-1320.16.2.115
    1. Agarwal H, Nakara A, Shanmugam VK (2019) Anti-inflammatory mechanism of various metal and metal oxide nanoparticles synthesized using plant extracts: a review. Biomed Pharmacother 109:2561–2572. https://doi.org/10.1016/j.biopha.2018.11.116 - DOI - PubMed
    1. Ahmed WMS HO (2015) Effect of atorvastatin and vitamin D on FreundÂ’s adjuvant-induced rheumatoid arthritis in rat. J Bioequiv Availab 07. https://doi.org/10.4172/jbb.1000221
    1. Alivernini S, Tolusso B, Petricca L, et al (2019) Rheumatoid arthritis. In: Mosaic of autoimmunity: the novel factors of autoimmune diseases. Elsevier, pp 501–526
    1. Cascão R, Vidal B, Raquel H et al (2012) Effective treatment of rat adjuvant-induced arthritis by celastrol. Autoimmun Rev 11:856–862. https://doi.org/10.1016/j.autrev.2012.02.022 - DOI - PubMed - PMC

Publication types

LinkOut - more resources